CS
VYGR icon

Credit Suisse’s Voyager Therapeutics VYGR Stock Holding History

Credit Suisse’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27,449
Closed -$130K – 4632
2021
Q1 		$130K Sell
27,449
-6,194
-18% -$42.2K ﹤0.01% 4171
2020
Q4 		$240K Buy
33,643
+9,609
+40% +$92.4K ﹤0.01% 4047
2020
Q3 		$257K Sell
24,034
-35,912
-60% -$422K ﹤0.01% 3733
2020
Q2 		$756K Buy
59,946
+33,029
+123% +$384K ﹤0.01% 3077
2020
Q1 		$247K Sell
26,917
-6,111
-19% -$70.1K ﹤0.01% 3542
2019
Q4 		$461K Buy
33,028
+12,713
+63% +$185K ﹤0.01% 3611
2019
Q3 		$350K Buy
20,315
+2,354
+13% +$49.4K ﹤0.01% 3624
2019
Q2 		$488K Buy
17,961
+4,685
+35% +$107K ﹤0.01% 3424
2019
Q1 		$255K Buy
13,276
+274
+2% +$3.57K ﹤0.01% 3672
2018
Q4 		$121K Buy
+13,002
New +$167K ﹤0.01% 3744
2018
Q3 		– Sell
-13,474
Closed -$264K – 4008
2018
Q2 		$264K Sell
13,474
-232
-2% -$4.58K ﹤0.01% 3673
2018
Q1 		$257K Buy
+13,706
New +$296K ﹤0.01% 3626
2017
Q4 		– Sell
-10,969
Closed -$226K – 4217
2017
Q3 		$226K Buy
+10,969
New +$124K ﹤0.01% 3879

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Credit Suisse's VYGR Position: Q2 2021 in Review

Credit Suisse sold out of Voyager Therapeutics (VYGR) in Q2 2021, closing a stake of 27,449 shares — an estimated $130K sold.

Credit Suisse first reported a position in VYGR in Q3 2017 and held it in 13 quarters. The position peaked at $756K in Q2 2020. 78 funds tracked by Wall St. Rank hold VYGR as of Q2 2021.

  • Credit Suisse reported no remaining Voyager Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Credit Suisse sold 27,449 Voyager Therapeutics shares in Q2 2021, an estimated $130K.
  • Credit Suisse first reported a position in Voyager Therapeutics in Q3 2017 and held it in 13 quarters.
  • Credit Suisse's Voyager Therapeutics position peaked at $756K in Q2 2020.
  • 78 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2021.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.